AmSurg (AMSG) Reports In-Line Q3 EPS, FY Rev. Guidance Tops Consensus

Go back to AmSurg (AMSG) Reports In-Line Q3 EPS, FY Rev. Guidance Tops Consensus

Wells Fargo Upgrades AmSurg (AMSG) to Outperform

November 2, 2016 6:36 AM EDT

Wells Fargo upgraded AmSurg (NASDAQ: AMSG) from Market Perform to Outperform.

For an analyst ratings summary and ratings history on AmSurg click here. For more ratings news on AmSurg click here.

Shares of AmSurg closed at $59.75 yesterday.

... More